HORSE LINE
MEDICINAL PRODUCTS
THE COMPANY ACME srl is an Italian company that develops, registers and sells products for the health and well-being of animals. It is particularly active in the sporting horse, racehorse and household pet sectors. The company has always placed great emphasis on pharmaceutical and clinical research. Strict compliance with laws on public and animal health is the hallmark of the work of the veterinarians, biologists and pharmacists who apply their know-how and experience to the attainment of the company’s goals. Cooperation with both public and private research agencies and institutes, veterinarians, breeders, trainers and owners ensures that Acme has comprehensive knowledge of the world of animals and the problems that afflict them. The mission of Acme is to produce scientific results that are useful for preventing and treating the major pathologies of both animals and mankind, and generally for improving the quality of life of people, animals, and for protecting the environment. Acme works in compliance with the latest GMPs at production facilities authorised by the Italian Ministry of Health for the manufacture of medicinal products for veterinary use. It also is authorised to produce and market supplemental and complete animal feeds, which are manufactured in dedicated areas.
index
Veterinary drugs
Bute Equimucil Equimucil Antibiotico Knock-out Megabron Noxaprim Opticortenol-s Socatil Strike Sungate
9 11 13 15 17 19 21 23 25 27
Solutions for fluid therapy
Sterile perfusional solutions
31
[ Veterinary drugs ] ACME Srl is a pharmaceutical company being working in veterinary field for more than 20 years. ACME directly takes care of development studies, including technical development, clinical studies as well as the registration procedures of its own innovative medicinal products. Our medicinal products are manufactured in compliance with the current EU GMP, in Manufacturing Sites authorized and regularly inspected by the EU Health Authorities.
Bute
BUTE Analgesic anti-inflammatory antipyretic
Composition
A potent non-steroidal analgesic anti-inflammatory agent, endowed with an antipyretic activity. It inhibits the permeability of the capillaries and reduces edema of inflammatory nature. Its action is comparable to low level doses of cortisone preparations, with respect to which it exerts also a central analgesic activity. This affords BUTE速 the capacity to reduce the onset of painful stimuli at a peripheric level and their perception at a central level. It can be administrated also to pregnant brood-mares.
ORAL PASTE one syringe contains: GRANULES one packet contains: INJECTION 100 ml of solution contains:
9
Phenylbutazone 2 g
Phenylbutazone 2 g
Sodium Phenylbutazone 20 g
[ Veterinary drugs ]
Indications for use
Warning
Symptomatic treatment of lameness, acute and chronic illnesses of the locomotive apparatus, such as arthritis, periarthritis, tendinitis, tenosynovitis, desmitis, neurites, myositis, podolaminitis, navicolar disease. Lesions to soft tissue such as bursitis, mastitis, hematomas, contusions, lacerations due to delivery. Surgical operations, inflammation therapy of the udder and post partum udder edema.
Not for use in horses intended for food.
How Supplied Box containing 20 packets, each containing 10 g of granules. Box containing 10 syringes with 10 g of paste. 100 ml multidose bottle.
Administration and Dosage ORAL PASTE: Acute diseases:
two syringes per day for 5 days, then one syringe per day.
Chronic diseases:
1 syringe per day for 10-20 days.
GRANULES: Acute diseases:
two packets per day for 5 days, then one packet per day.
Chronic diseases:
one packet per day for 10-20 days.
INJECTIONS: Acute diseases:
15-25 ml per day for 5 days for a horse.
Chronic diseases:
10 ml per day for 10-20 days.
10
Equimucil
EQUIMUCIL
Real mucolytic Acetylcysteine is a real mucolytic that fluidizes mucosal or mucopurulent secretion of the respiratory ways. It’s prompt and effective action is due to the free sulphhydryl group (-S-H) which is able to attack and break sulphur links S-S that cause aggregation of proteins in mucus resulting in high viscosity. Acetylcysteine action on any purulent component of secretions is due to its ability to depolymerize nucleic acids. As a consequence of its mucolytic action EQUIMUCIL reduces risk of complications caused by thick mucus secretions and consequent reduced respiratory function. NAC also improves the antioxidant system one of the
most important intracellular defense mechanisms. By promoting cellular glutathione synthesis, acetylcysteine can counteract damaging compounds such as dust and air pollutants frequently inhaled by the horse. NAC, antagonizes the free radicals of oxygen that are largely responsible for degenerative inflammation of the lung in horse. By blocking the oxidative action of hypochlorous (HClO-) radical, acetylcysteine is able to protect alfa-1-antitrypsin. Alfa-1-antitrypsin is an effective inhibitor of elastase and collagenase, the proteolytic enzymes, which act on the alveolar walls causing the onset of emphysema. 11
[ Veterinary drugs ]
COMPOSITION INJECTABLE 100 ml contain: GRANULATED a packet contains
20 g of N-acetylcysteine
2.5 g of N-acetylcysteine
Indications for use
HORSE WEIGHT
EQUIMUCIL DOSAGE packets for 3-5 days
EQUIMUCIL DOSAGE packets for 7-10 days
125 kg
1 ml
1/2 ml
250 kg
2 ml
1 ml
375 kg
3 ml
1,5 ml
500 kg
4 ml
2 ml
may result in increased coughing, respiratory noise and nasal running during the first few days of treatment. This generally diminishes and then disappears, with the respiratory tract clearing. In cases of bacterial infections, the product should be combined with an adequate antibacterial treatment.
Oral treatment of the clinical disorders of the equine respiratory system, including but not limited to: laryngitis, bronchitis, acute or chronic pneumonia, including chronic obstructive pulmonary disease (COPD), when mucolitic activity is advisable as in presence of mucous or muco-purulent secretions, and in pulmonary emphysema (also known as short windedness).
Withdrawal period Zero days.
Dosage and Administration
How Supplied
INJECTABLE administer 5-10 mg intravenously of Acetilcisteina for each kilo of bodyweight, for 5-15 days according to the clinical evolution of the illness.
100 ml multi-dose bottle with perforated top Box containing 20 packets, each containing 5g of granules.
GRANULES Foals:1 packet per day, equal to 2,5 g of ACETYLCYSTEINE. Horses: 2 packet per day, equal to 5 g of ACETYLCYSTEINE.
SUGGESTED ASSOCIATIONS: NOXAPRIM-MEGABRON
Warning The strong fluidifying effect on bronchial secretion
12
Equimucil antibiotico
EQUIMUCIL ANTIBIOTICO Antibiotic 4.05 g
The active ingredient of EQUIMUCIL ANTIBIOTIC is a molecule with two pharmacological effects that enhance the therapeutic activities of the individual components, one is an important antibacterial (thiamfenicol), the other has an important functional effect (acetylcisteine). This combination induces a more rapid and efficacious healing process. The active ingredient is THIAMFENICOL (TMF) – glycinate –acetylcisteine – an insoluble compound obtained through the esterification of Thiamfenicol with glycine and the successive salification with ACETYLCISTEINE (AC). TMF is a wide spectrum
antibiotic; it is active against Gram-positive bacteria (Clostridium spp., Corynbacterium spp., Eripypelothrix rhusiopathiae, Haemophilus pleuropneumoniae, Lysteria spp,: Staphylococcus spp. and Streptococcus spp.), Gram-negative bacteria (Bordetella spp., Bricella spp., Klebsiella spp., Pasturella spp., Shigella spp., Treponema spp. and anaerobic bacteria), Mycoplasms and Rickettsiae. The mechanism of action of TMF involves blocking bacterial protein biosynthesis. A bacteriostatic action usually results; this will become bacteriocidic at concentrations that are just slightly greater than the minimum inhibitory concentrations 13
[ Veterinary drugs ] tested on in vitro bacterial cultures. Bacterial strains resistant to TMF rarely appear and in the event drugresistance is detected, it usually will cross-over with other antibiotics of correlated chemical structure. The antibacterial properties of TMF contained in EQUIMUCIL ANTIBIOTIC are associated with the mucolytic, anti-inflammatory and tissue-tropic properties of AC (see Equimucil).
red every twelve hours for 3-5 days.
Warning Maximum attention must be paid to improving the stabling conditions to remove every stressor. Repeated or prolonged use of EQUIMUCIL ANTIBIOTIC should be avoided. Improvements should be made to the management practices and by cleaning and disinfecting each of the destination animals. The product should only be used once germ-sensitivity to the product has been determined. An antibiogram is advisable prior to commencing treatment. Do not use in animals with known hypersensitivity to the active ingredient or any of the excipients.
Composition Thiamphenicol-glycinate-acetylcysteinate Equivalent to thiamphenicol Acetylcysteine
4.05 g 2.50 g 1.15 g
Withdrawal period Destination species
Not pertinent.
Equines not destined for the human food chain.
How Supplied Indications FOR USE
A box containing a bottle of the lyophilized pharmaceutical product and 20 ml bottle containing the solvent for the preparation of the injectable solution.
Therapy of equine influenza or Hoppengarten’s cough, laryngo-tracheitis, bronchitis, influenzal bronchial pneumonia.
Dosage and administration Reconstitute the solution of EQUIMUCIL ANTIBIOTIC by adding the solvent to the lyophilized powder. Shake well. The resulting product (TMF) is administered by intramuscular injection at a daily dosage of 15-50 mg/kg live body weight. The dose is dependent on the animal’s age and weight and is usually equivalent to 2 – 2.5 bottles / animal / day. The dose is split into two equal portions administe-
14
Knock-out
KNOCK-OUT Muscle relaxant for race horses KNOCK-OUT速 is an intravenous, central-acting skeletal muscle relaxant. It acts centrally through the transmission block of the nerve impulses of the neurons in the spinal cord, in the encephalic trunk and in the sub-cortical areas of the brain. It has analgesic properties. The presence of glucose in the preparation reduces the risk of intra-vasal hematolysis.
In particular, its association with barbiturates attenuates the risk of respiratory paralysis linked to their overdose. At the recommended doses, the effects of KNOCK-OUT速 are so secure that it may be applied in all anesthesia, especially when the horse runs a higher risk. KNOCK-OUT速 causes a rapid laying-down of the horse that lasts between 15 and 30 minutes, even without an anesthetic premedication. Associated with barbiturates it determines a
KNOCK-OUT速 notably reduces the amount of anesthetics needed for surgical operations.
15
[ Veterinary drugs ]
slow and monitored induction of anesthesia and a calm and rapid awakening which notably reduces pre- and post-operative trauma. It also shortens post-operative decubitus thus diminishing lesions caused by arterial hypoxaemia.
weighing 500 kg. Veterinary medicinal product for non-food producing horses.
How Supplied Box containing 500 ml PVC bag
Composition One 500 ml bag contains: Guaifenesin Glucose
40.0 g 27.5 g
Indications for use • Pharmacologic laying-down of horse associated with a short and light level of anesthesia; • to facilitate the tracheal intubation; • to limit pre- and post-operative trauma; • to facilitate, through muscle relaxation, surgical-orthopedic maneuvers.
Administration and Dosage Administer quickly intravenously 80 mg of guaifenesin per kg of body weight, by applying sufficient pressure on the bag. A sac containing 500 ml of KNOCK-OUT® administered at a time is sufficient to lay down a horse
16
Megabron
MEGABRON Lasting-acting bronchodilator MEGABRON 速 is a potent xanthic bronchodilator that acts as a muscle relaxant of plain muscles of the bronchi. It stimulates the phrenic nerve thus generating a worthy increase of the transdiaphragmatic pressure, which becomes an improvement in air exchange. MEGABRON 速 explicates different desirable side effects it dilates the coronary arteries, stimulates the myocardium with a cardiokinetic effect, and stimulates the bulbar respiratory center and those of the striated muscles with an increase of the muscular contraction intensity. It produces peripheral vasodilatation and increases diuresis. The hematic levels that have proved to be therapeutically efficient
are between 5 and 20 mcg/ml, with ample individual oscillations due to the age of the horse and to the eventual presence of cardiac or hepatic diseases. MEGABRON 速 (contains microencapsulated theophylline (MICRO-CAPS速). This allows a gradual release of the active ingredient, and the achievement of valid plasmatic levels without adverse reactions, with one administration every 12 hours. After single administration of the advised dosage, the active drug reaches its maximum plasmatic concentration in 4-5 hours, only to gradually decrease and disappear from blood after 72 hours. Accumulation of cyclic AMP. 17
[ Veterinary drugs ]
Composition A packet contains:
must not be exceeded.
Withdrawal period
Theophylline 3,7 g
No withdraw period
Indications for use
How Supplied
Treatment of the reversible bronchospastic status associated with acute bronchitis, chronic bronchitis, chronic obstructive pulmonary disease (COPD), chronic pulmonary emphysema (so-called heaves), and correlated symptoms: cough, dyspnea and quick tiredness. Treatment of acute and chronic bronchopneumonia and of cor pulmonale.
Box containing 20 packets, each containing 3,85 g of granules.
RECOMMENDED ASSOCIATIONS:
MEGABRON ® may be successfully associated with antiEQUIMUCIL - VETEMUCIL – NOXAPRIM
biotics, sulphonamides and mucolytics. In the prophylaxis of allergy-based respiratory pathologies, the administration of MEGABRON ® should precede contact with the allergens (dust, mold, pollen, etc.) to which the horse is sensitive.
Administration and Dosage The dosing of MEGABRON ® should be in respect to the horse’s weight. Generally the recommended average dosing is about 5-10 mg of theophylline per Kg of body weight. Horses: From 0,5 to 1,5 packets every 12 hours according to the weight and severity of the horse’s conditions. Foals: From 0,25 to 1 packet every 12 hours according to the weight and the seriousness of horse’s condition. In young horses the dose of 10 mg per Kg of weight
18
Noxaprim
NOXAPRIM Chemiotherapeutic oral paste
Composition
It acts through the sequential double block of the bacterial metabolism by depriving the bacteria of the nucleic acids that are essential for their survival and their multiplication. Even though both Trimethoprim and sulphamethoxazole are antifolics, they do not cause deficiency of folic acids in horses. Sulphamethoxazole was chosen in virtue of its low pharmacoproteic bond that allows the passing of the hematoencephalic barrier and the diffusion in tissues that are not correctly irrorated (abscess, phlegmon, empyema, organs that are prone to acute inflammatory processes).
One 40 g syringe contains: Trimethoprim Sulphamethoxazole
2.68 g 13.32 g
One 100 g syringe contains: Trimethoprim Sulphamethoxazole
19
6.7 g 33.3 g
[ Veterinary drugs ]
Indications for use
as maintenance dose. It is advised to subdivide the daily administration in two half doses every 12 hours. Eventual episodes of resistance to the association of Trimethoprim-sulphamethoxazole may be overcome with an increase in dosage due to its mass action.
Treatment of Respiratory infections: laryngitis, tracheitis, cronic and acute bronchitis, bronchopneumonia, pneumonia, pleuritis, pleuropneumonia, equine adenitis, abscess of the guttural pouches, etc. Urogenital infections: cystitis, urethritis, pyelitis, nephrytis, metritis, mastitis, vaginitis, orchitis, balano-posthitis, etc. Gastrointestinal infections: gastritis, enteritis, colitis, during resolution of colic syndrome or in the medium and long-term post-operative course of surgical operation of the gastrointestinal tracts. Skin and soft tissue infections: pyoderma, abscess, casual or surgical wounds, burn, etc. Skeletal infections: septic arthritis and arthrosynovitis, bacterial diseases of the living part of the foot (“stud wounds�), osteomyelitis, etc.
DESTINATION SPECIES Veterinary medicinal product for non food-producing horses.
How Supplied Box containing 5 syringes with 40 g of oral paste. Box containing 2 syringes with 100 g of oral paste.
Administration and Dosage ORAL USE Adult horses: 1 to 1,5 syringes containing 40 g of paste or half syringe containing 100 g of paste per day as beginning dosage; half or 2/3 syringe containing 40 g of paste or 1/4 syringe containing 100 g of paste per day as maintenance dose. Foals or ponies: 0,5 to 1 syringe containing 40 g of paste or 1/5 or 1/4 syringe containing 100 g of paste per day as beginning dosage; a quarter or half syringe containing 40 g of paste or 1/10 syringe containing 100 g of paste per day
20
Opticortenol-s
OPTICORTENOL-S Fast and long lasting injectable suspension made of two glucocorticoids OPTICORTENOL-S速 protects against cell damages, stabilizes phospholipidic membranes and inhibits phospholipase that cause the arachidonic acid, leucotrienis as well as thromboxanes to be liberated. As a consequence prostaglandin is prevented which causes swelling.
Fast
life saver!
Strong
works with reduced dosages!
Efficient
notable clinical improvements!
Long lasting
it stays in effect longer!
Manegable
wider dosage range!
Tollerable it can be administered with many different means with an absence of tissue reactions!
OPTICORTENOL-S速 is a strong and long lasting antiinflammatory and antiallergenic product which has an influence on the hydro-saline balance.
Safe
21
no undesirable effects
[ Veterinary drugs ]
Composition
intramuscular, subcutaneous, intra peritoneal as well as locally (intra articular injection).
1 ml of suspension contains: Active ingredients: Dexamethasone trimetilacetate Prednisolone
Warning
2.50 mg 7.50 mg
Veterinary medicinal product for non food-producing horses.
Administration and Dosage How Supplied Horses
6 – 10 ml/head
Foals
1 – 3 ml/head
Local (intrarticular) treatment
1 – 3 ml
Box containing one 20 ml bottle.
Administer a second injection after 2-5 days if it is absolutely necessary.
Indications for use OPTICORTENOL-S® is to be administered to carry out general or local cortical therapy. OPTICORTENOL-S® promotes glycogenesis and has an anti-inflammatory, anti-allergenic and anti-toxic effect, in addition it stimulates general defenses. The main disorders that it treats are: arthritis, synovitis, inflammation of tendon sheaths, strains, itchiness, eczema, dermatitis, as a remedy for infective illnesses as well as possible complications. OPTICORTENOL-S® s particular tolerability makes it possible to administer in many different ways: intravenous,
22
Socatil
SOCATIL Skin and soft tissues lesions SOCATILŽ paste for topical use for horses not intended for human consumption – is a paste based on formosulfathiazole, a sulfamide potentiated through the condensation of sulfathiazole with formaldehyde. It has an intense bacteriostatic action. Because of their structural analogy, sulfathiazole competes with p-aminobenzoic acid (PABA) in the interaction with folate-synthetase for the formation of folic acid, leading eventually to inhibition of growth and multiplication of the micro-organisms.
Sulfathiazole is generally active against both Grampositive and Gram-negative bacteria, some strains of Clamydia, Nocardia, Actinomices spp, some protozoas such as coccids and Toxoplasma spp. Some strains of Pseudomonas, Klebsiella, Proteus, Clostridium, Leptospira spp. and rickettsia also demonstrate a high degree of sulfamide resistance. The insensitivity of a microorganism to a specific sulfamide usually extends to include other members of this class of active ingredients. With Gram-negative intestinal bacteria, the plasmid23
[ Veterinary drugs ]
mediated sulfamide-resistance is often associated with resistance to ampicillin and the tetracyclines.
paste for topical use for horses not intended for human consumption - every 12 hours for 21 days or until the lesions have healed, in a quantity sufficient to completely cover the lesion.
Composition How Supplied
100 g of paste contains 50 g of formosulfathiazole
Box containing 2 syringes with 100g of paste.
Indications for use • Intense bacteriostatic and antiparasitic action. • Absence of re-absorption, therefore there is a high concentration in the organ being treated. • High adhesiveness with the damaged tissue. • Lesion solidification, with external use, as well as the creation of a protective barrier regarding micro organismsand insects. • Liquid absorption from secreted and oedematous tissues • Low toxicity.
Administration For topical use
Dosage To treat lesions of the skin and the soft tissues, use the spatula supplied to apply the product - SOCATIL®
24
Strike
STRIKE Horse deworming Strike is an anthelminthic that is well tolerated not only by horses and ponies that are milking and weaning but, also by those that are pregnant even when administering dosages that are 6 times the indicated suggestion for therapy.
Pyrantel, which is the active ingredient in Strike, is a powerful acetylcholine agonist receptor; it takes action on the parasite’s nervous system by inhibiting colinesterasis and consequent abnormal ganglionic cholinergic stimulation. It acts to block the depolarizing neurons which follows muscular contractions and irreversible motor paralysis. Therefore the parasite dies, is detached from the intestinal walls, and is expelled from the gastrointestinal tract. Pyrimidine, deriving from the pyrantel family is safe and has low toxicity in mammals since it isn’t well absorbed by the gastro intestines.
• Completely efficient with strongyle up until 30 days after treatment • Safe and managable • Reduces pasture contamination Pyrantel is effective on larva and it prevents strongyle and ascarid infestation, because when the larva’s intestinal lumen are killed it prevents 25
[ Veterinary drugs ]
ORAL PASTE:
adult parasite evolution with a considerable reduction in pasture contamination.
• Gastrointestinal disorders caused by strongyle: 5 g of paste for 100 Kg of body weight in single administration. • Gastro intestinal disorders caused by Cestoda (taenia): 10 g of paste for 100 Kg of body weight in single administration.
• Practical • Desireable • Economical
Composition
USE WITH PREGNANCIES AND LACTATION
100 g granules contain: Pyrantel pamoate (equal to 6,94 g of Pyrantel base).
20 g
Strike can be tolerated during all phases of pregnancy and lactation.
38 g
Withdrawal period
100 g of paste contain: Pyrantel pamoate (equal to 13,2 g of Pyrantel base).
No withdraw period.
Indications for use How Supplied
Treats horse gastrointestinal disorders caused by strongyle (es. Strongylus vulgaris, S. edentatus, S. equinus) and Cestoda (taenia) (es. Anoplocephala magna, Anoplocephala perfoliata).
Box containing 4 packets, each containing 25 g of granules. Box containing 40 packets, each containing 25 g of granules. Jar containing 1 Kg of granules with a 25 g measuring cup. Box containing 1 syringe with 25 g of paste. Box containing 1 syringe with 50 g of paste. Box containing 20 syringes with 25 g of paste. 1 tube containing 300 g of paste.
Administration and Dosage GRANULES: A 25 g packet or a 25 g dosage for every 250 kg (10 g for 100 kg ) in single administration.
26
Sungate
SUNGATE
Composition
SUNGATE is an anabolic-androgenic steroid belonging to the alkyl group 17a. It takes action on regenerative therapy during aseptic arthropathy in horses, with degeneration of the articular cartilage and with altered articular functionality of the synovial membrane, also associated with scarce or altered viscous-elastic characteristics of synovial fluid.
1 ml of suspension contain:
Stanozolol
27
5 mg
[ Veterinary drugs ]
Use and Dosage
consumption. Special Precautions for use Special precautions for use in animals. The normal asepsis practices are to be respected during administration. Special precautions to be taken by the person administering the medicinal product to animals. People with known hypersensitivity to stanozolol or to any one of the excipients must avoid contact with this veterinary product. The product must not to be administered by pregnant women. It’s recommended to use gloves and safety glasses to avoid the contact with skin and eyes. In case of accidental selfinjection, seek medical advice immediately and show the package leaflet or the label to the physician.
Administration route: intra-articular injection.
Administration and Dosage 1 ml of suspension (5 mg stanozolol) in medium sized articulation joint such as hock and fetlock once a week. Weekly administration may be performer up to six times depending on severity of arthropathy and it’s stage of deterioration. In smaller joints (joints of ponies, foals or interphalangeal joints) dosing can be proportionally reduced to 1.0-2,5 mg. Insert the needle in the articular cavity, if the needle is correctly positioned synovial liquid will leak out. Connect the syringe to the needle and inject the product. In chronic arthropathy it may take up to a month before noticing first signs of clinical healing. Improvement will be constant and durable. This long latency period is due to the time needed by the product to perform its regenerative action. Proper rehabilitation exercises will help regeneration of tissues and lead to a faster recovery.
How Supplied Box containing one disposable pre-loaded syringe and sterile needle.
Warning Not for use in horses intended for food.
Withdrawal Period Not applicable. The product must not be administered to horses that are destined to food production for human
28
[ Solutions for fluid therapy ] Acme srl holds the Italian Marketing Authorization of a complete line of IV Fluids for the infusion therapy of horses. Our sterile IV Fluids are manufactured in compliance with the current EU GMP, in Manufacturing Sites authorized and regularly inspected by the EU Health Authorities.
Solutions
LACTATED RINGERS Electrolytic-alkalizer rehydrating solution Intravenous, hypodermic, intraperitoneal administration. Dosage: according to veterinarian’s assessment. Adult horses: 3,000 ml to 30,000 ml per day. Foals: 1,500 ml to 15,000 ml per day. Presentation:
31
500-1,000-2,000-5,000 ml PVC sac.
[ Solutions for fluid therapy ]
LACTATED RINGERS WITH GLUCOSE 5%
ELECTROLYTIC “R” SOLUTION
Electrolytic-alkalizer rehydrating energy-giving solution
Isotonic and isoionic at physiological ph rehydrating solution
Intravenous, hypodermic, intraperitoneal administration. Dosage: according to veterinarian’s assessment.
Intravenous, hypodermic, intraperitoneal administration. Dosage: according to veterinarian’s assessment.
Adult horses: 3,000 ml to 30,000 ml per day. Foals: 1,500 ml to 15,000 ml per day.
Adult horses: 2,000 ml to 3,000 ml per day. Foals: 2,000 ml to 15,000 ml per day.
Presentation:
Presentation:
2,000 ml PVC sac.
2,000 ml PVC sac
PHYSIOLOGICAL SOLUTION NaCl 0,9%
GLUCOSE 33%
Detoxicating-isotonic rehydrating solution
Steril perfusional solution, apirogen, ipertonic
Intravenous, hypodermic, intraperitoneal administration. Dosage: according to veterinarian’s assessment.
Intravenous administration. Dosages: under vet assessment.
Adult horses: 2,000 ml to 30,000 ml per day. Foals: 2,000 ml to 15,000 ml per day.
Horses Foals:
ml 2.000 - 10.000 per day. ml 1.500 - 15.000 per day.
Presentation:
Presentation:
500 ml polypropylene bottle
500-1,000-2,000-5,000 ml PVC sac.
32
LEVULOSE 20% Detoxicating rehydrating energy-giving solution
Solutions
Horses: Intravenous slow administration 1,000 to 10,000 ml per day according to the assessment by the responsible veterinarian. Foals: half dose. Presentation:
1,000 ml PVC sac
STERILE WATER FOR INJECTION Presentation:
33
1000-2000 ml PVC sac.
Graphic design Orto_Grafico comunicazione - Albinea (RE), ITALY Visual and post-production Spaghetti 3D - Reggio Emilia, ITALY Edition 221013
w w w.ac med rug s .c om fa ceb ook .c om/ac mes r l fa ce b o o k .c om/ACMEINTERNATIONAL
ACME Srl _ via Portella della Ginestra 9, 42025 Cavriago (RE) _ Italy _ Tel: +39 0522 941919 _ tech.info@acmedrugs.com